Premium
P3‐073: CSF Aβ42, Tau and phosphorylated Tau are biomarkers for Alzheimer's disease neuropathology and predict development of Alzheimer's disease in patients with mild cognitive impairment
Author(s) -
Herukka Sanna-Kaisa,
Tapiola Tero,
Hallikainen Merja,
Tervo Susanna,
Helisalmi Seppo,
Pennanen Corina,
Alafuzoff Irina,
Soininen Hilkka,
Pirttilä Tuula
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1637
Subject(s) - neuropathology , dementia , medicine , disease , alzheimer's disease , cognitive impairment , tau protein , pathology , cerebrospinal fluid , oncology , psychology